NSE filing, NSE: KARURVYSYA. Summary written from the filing by ALFA Finder's alert engine.
Karur Vysya Bank Ltd: key numbers
- Share price
- ₹350.20
- Market cap
- ₹33,854 Cr
- Revenue (annual)
- ₹11,074 Cr
- Net profit (annual)
- ₹2,510 Cr
- P/E (TTM)
- 11.4×Sector 19.7×
- Promoter holding
- 1.95%-0.12% QoQ
- FII holding
- 18.10%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Karur Vysya Bank Ltd
All →Karur Vysya Bank Capacity Expansion
Karur Vysya Bank will inaugurate eight new branches on October 30, 2026, across several states. No financial amount is disclosed, so the filing reports branch expansion only.
- new branches
- 8.0 branches
Karur Vysya Bank Promoter Buying (Off-Market)
Karur Vysya Bank promoters executed an inter-se transfer of 3,00,000 shares within the promoter group on 23 October 2026. Net promoter group holding is unchanged, and no consideration was disclosed.
- Promoter stake change
- +0.02%
Karur Vysya Bank Promoter Selling: ₹0.93 Cr
Promoter A J Suriyanarayana sold 25,000 Karur Vysya Bank shares on the market on 19 October 2026. The trade was valued at Rs.0.93 Crore.
- Value
- ₹0.93 Cr
Karur Vysya Bank Promoter Selling: ₹0.23 Cr
Promoters and promoter group members of Karur Vysya Bank sold a total of 6,000 equity shares through open market transactions.
- Value
- ₹0.23 Cr
Karur Vysya Bank Promoter Selling: ₹0.07 Cr
Promoter and Promoter Group members sold 2,000 equity shares of Karur Vysya Bank Ltd in the open market.
- Value
- ₹0.07 Cr
Karur Vysya Bank Other Announcement
Karur Vysya Bank has revised its Marginal Cost of Funds Based Lending Rates (MCLR) effective from 22nd October 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date